Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 83, 2024 May 24.
Article
in En
| MEDLINE
| ID: mdl-38790033
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Cancer Res
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom